What is the role of the sponsor in managing trial issues?

Boost your GCP E6 (R3) exam readiness. Improve your understanding with engaging, insightful questions. Test yourself with hints and detailed explanations. Prepare effectively!

Multiple Choice

What is the role of the sponsor in managing trial issues?

In trial management, issues must be handled through a structured process that protects participant safety, rights, and the integrity of the data. The sponsor is responsible for overseeing this process and ensuring that any problem is identified, assessed for severity and impact, and then escalated to the right people at the right time. Once an issue is escalated, the sponsor coordinates or directly implements the necessary corrective and preventive actions and follows up to verify they’ve been completed and effective. This ongoing oversight helps prevent recurrence and keeps the trial compliant with regulatory and ethical standards. This is why the best approach is for the sponsor to ensure appropriate and timely escalation and follow-up of issues to implement necessary actions. It reflects accountable sponsor oversight of quality and safety throughout the study. Why the other ideas don’t fit: issues aren’t solely the investigator’s responsibility, since the sponsor remains ultimately accountable for trial quality and safety; the sponsor should participate in issue resolution and oversight rather than staying hands-off; and waiting for regulatory approval before escalating misses the urgent need to protect participants and data, as many issues require immediate action long before any regulatory step.

In trial management, issues must be handled through a structured process that protects participant safety, rights, and the integrity of the data. The sponsor is responsible for overseeing this process and ensuring that any problem is identified, assessed for severity and impact, and then escalated to the right people at the right time. Once an issue is escalated, the sponsor coordinates or directly implements the necessary corrective and preventive actions and follows up to verify they’ve been completed and effective. This ongoing oversight helps prevent recurrence and keeps the trial compliant with regulatory and ethical standards.

This is why the best approach is for the sponsor to ensure appropriate and timely escalation and follow-up of issues to implement necessary actions. It reflects accountable sponsor oversight of quality and safety throughout the study.

Why the other ideas don’t fit: issues aren’t solely the investigator’s responsibility, since the sponsor remains ultimately accountable for trial quality and safety; the sponsor should participate in issue resolution and oversight rather than staying hands-off; and waiting for regulatory approval before escalating misses the urgent need to protect participants and data, as many issues require immediate action long before any regulatory step.

More practice questions